Philip Toleikis
Corporate Officer/Principal bij Medway Working Group
Vermogen: 1 M $ op 31-05-2024
Actieve functies van Philip Toleikis
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Medway Working Group | Corporate Officer/Principal | - | - |
Loopbaan van Philip Toleikis
Eerdere bekende functies van Philip Toleikis
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SERNOVA CORP. | Directeur/Bestuurslid | 19-10-2010 | 30-04-2024 |
| Algemeen Directeur | 28-04-2009 | 05-09-2023 | |
| Hoofd Techniek/Wetenschap/O&O | 05-09-2023 | 30-04-2024 | |
| Investor Relations Contact | - | 28-07-2014 | |
| Public Communications Contact | 19-10-2010 | 28-07-2014 | |
| President | 28-04-2009 | 05-09-2023 | |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Hoofd Techniek/Wetenschap/O&O | 01-01-2006 | 01-01-2006 |
Opleiding van Philip Toleikis
| University of British Columbia | Doctorate Degree |
| University of Michigan | Graduate Degree |
| University of Vermont | Undergraduate Degree |
Statistieken
Internationaal
| Canada | 5 |
| Verenigde Staten | 3 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SERNOVA CORP. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
| Medway Working Group |
- Beurs
- Insiders
- Philip Toleikis
- Ervaring
